A pilot randomised clinical trial of mepolizumab in COPD with eosinophilic bronchitis

Eur Respir J. 2017 Mar 15;49(3):1602486. doi: 10.1183/13993003.02486-2016. Print 2017 Mar.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bronchitis / complications*
  • Double-Blind Method
  • Eosinophils / drug effects*
  • Female
  • Humans
  • Male
  • Pilot Projects
  • Pulmonary Disease, Chronic Obstructive / drug therapy*
  • Sputum / cytology

Substances

  • Antibodies, Monoclonal, Humanized
  • mepolizumab

Associated data

  • ClinicalTrials.gov/NCT01463644